Standard strategies for diagnosis and treatment of patients with newly diagnosed Parkinson disease
JAPAN
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
In Japan, diagnosis of Parkinson disease (PD) is based on the United Kingdom PD brain bank criteria,1 including comprehensive physical examination and additional ancillary investigation, routinely a cerebral MRI. 99mTc hexamethyl-propyleneamine oxime SPECT analysis is optional with attending neurologists. Striatal dopamine transporter binding measured using β-carboxymethyoxy-3-β-(4-iodophenyl) tropane (CIT) SPECT is not available on a practical basis. Instead, an examination using 123I-metaiodobenzylguanidine myocardial scintigraphy has been available even at local hospitals, which is useful in differentiating PD from parkinsonian variants with high sensitivity and specificity.2
Footnotes
Study funding: No targeted funding reported.
Disclosures: S-i. Kubo, T. Hatano, and G. Oyama report no disclosures. N. Hattori serves on the editorial boards of Movement Disorders and the Journal of Neural Transmission. Full disclosure form information provided by the authors is available with the full text of this article at Neurology.org/cp.
- © 2013 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
The Nerve!: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.